FDA Should Share Drug Name Evaluation Software With Sponsors, PhRMA Says

FDA should share Phonetic and Orthographic Computer Analysis software and databases with sponsors, the Pharmaceutical Research & Manufacturers of America said at an FDA Drug Safety & Risk Management Advisory Committee meeting Dec. 5